Factor VIIa-CTP

N/A

Report date: 2022/01/17 12:14:22

Base Information

Drug NameFactor VIIa-CTP
Drug Alias NameFVII-CTPMOD-5014MOD-5017OPK88005
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionCoagulation factor IX stimulantsCoagulation factor X stimulantsBlood coagulation pathway activation +[4] 
TargetsCoagulation factor IXCoagulation factor X
Therapy Area/IndicationsHemophilia BHemophilia ABlood Coagulation Disorders, Inherited
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIsrael
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOpko Health IncProlor Biotech
China Registration ClassN/A

Develop Information

Active CompaniesLeadermed Group LtdOpko Health Inc
Inactive CompaniesN/A
Active IndicationsHemophilia BHemophilia A
Inactive IndicationsBlood Coagulation Disorders, Inherited

Other Information

ATC CodeN/A
Related LinksN/A